Top Health-care stocks:
Health-care shares were mixed in pre-market trade on Wednesday.
In health-care stocks news, Trillium Therapeutics Inc. ( TRIL ), a clinical stage immuno-oncology company, has initiated dosing in its Phase 1 clinical trial of anti-tumor treatment TTI-621.
Shares in the company were flat at $7.93 pre-bell. The company has traded between $7.16 and $29.92 over the past 52 weeks.
Shares in the company were 1.2% lower at $49.79 pre-bell. The company has traded between $45.69 and $61.70 over the past 52 weeks.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.